Showing 181 - 200 results of 1,132 for search '"immunosuppressant"', query time: 0.05s Refine Results
  1. 181
  2. 182
  3. 183

    Use of Cyclosporine in Uterine Transplantation by Srdjan Saso, Karl Logan, Yazan Abdallah, Louay S. Louis, Sadaf Ghaem-Maghami, J. Richard Smith, Giuseppe Del Priore

    Published 2012-01-01
    “…Cyclosporine A (CsA) is an immunosuppressant widely used by transplant recipients. …”
    Get full text
    Article
  4. 184

    Dermatological Disorders following Liver Transplantation: An Update by Dipesh Kumar Yadav, Xue li Bai, Tingbo Liang

    Published 2019-01-01
    “…Patients undergoing liver transplantation (LT) are at a high risk of dermatological complications compared to the general population as a result of long-term use of immunosuppressant. However, the risk is not as high as other solid organ transplantations (SOT), particularly for skin cancer. …”
    Get full text
    Article
  5. 185

    Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation by Brian P. Boerner, Clifford D. Miles, Vijay Shivaswamy

    Published 2014-01-01
    “…Renal function and immunosuppressant levels remained stable. Analysis of long-term followup (32.5 ± 17.8 months) revealed that 17/22 patients remained on sitagliptin (mean hemoglobin A1c < 7%) with 9/17 patients remaining on sitagliptin alone. …”
    Get full text
    Article
  6. 186

    Long-Term Follow-Up after Intravenous Immunoglobulin Therapy in Patients with Severe Ocular Mucous Membrane Pemphigoid Unresponsive to Conventional Therapy by Stefania Leuci, Massimo Amato, Elena Calabria, Raffaele Piscopo, Fausto Tranfa, Gianrico Spagnuolo, Michele Davide Mignogna

    Published 2018-01-01
    “…In its most severe forms, this disease needs systemic therapy, usually based on steroids and immunosuppressant agents. In unresponsive cases or in the presence of contraindications or severe side effects due to conventional systemic corticosteroid and/or immunosuppressant therapy, a therapy shift to high-dose intravenous immunoglobulins (IVIg) has been recommended in other reports. …”
    Get full text
    Article
  7. 187

    The hope as social commitment in the processing of tacrolimus by Alessandra Suzin Bertan, Marco Aurélio Cremasco

    Published 2020-10-01
    “… The 2020 year shows the fragility of the human been due to a virus that affects the people dependent of immunosuppressant agents. The aim of this paper it to contextualize the importance of the hope as essential element in chemical design to obtain tacrolimus, and to professionals involved in this research. …”
    Get full text
    Article
  8. 188
  9. 189

    Polyoma BK Virus: An Oncogenic Virus? by Syed Hassan, Zaid Alirhayim, Syed Ahmed, Syed Amer

    Published 2013-01-01
    “…He subsequently developed BK virus nephropathy related to chronic immunosuppressant therapy. Three years later, misfortune struck again, and he developed adenocarcinoma of the bladder.…”
    Get full text
    Article
  10. 190

    A Case of Peripheral Ulcerative Keratitis Associated with Autoimmune Hepatitis by Hamoon Eshraghi, Aria Mahtabfar, Mohammad H. Dastjerdi

    Published 2017-01-01
    “…The patient was treated with topical and systemic steroids, immunosuppressant drugs (azathioprine and mycophenolate mofetil), a biologic (rituximab), and surgery (conjunctival resection), and the peripheral ulcerative keratitis epithelialized but ultimately led to corneal perforation. …”
    Get full text
    Article
  11. 191

    Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy by Nida Iqbal, Vinod Raina

    Published 2014-01-01
    “…Cyclosporine, an immunosuppressant, has shown good responses in relapsed/refractory SPTL; however its use in first line setting is not well established. …”
    Get full text
    Article
  12. 192

    Epidermodysplasia Verruciformis: A Clinicopathologic Review of Two Cases by Tummidi Santosh, Tanya Sharma, Deepti Joshi, Dinesh Prasad Asati, Sanjeev Vijay Choudhary, Neelkamal Kapoor

    Published 2025-01-01
    “…It can also occur as an acquired entity in patients with immunocompromised status, human immunodeficiency virus (HIV) infection, and immunosuppressant therapy. Hereby, we report two cases of EV, histologically diagnosed on skin punch biopsy, both presented with a clinical history of macular/verrucous lesions in various sun-exposed body regions. …”
    Get full text
    Article
  13. 193

    Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases by Matthew Koslow, Mehrnaz Maleki-Fischbach, Rebecca C. Keith

    Published 2021-01-01
    “…In the absence of guidelines regarding how CTD-ILDs should be treated, clinicians face difficult decisions on when to use immunosuppressant and anti-fibrotic therapies. The importance of a multidisciplinary and individualized approach to the diagnosis and management of CTD-ILD is highlighted in the three case studies that we describe in this article.…”
    Get full text
    Article
  14. 194

    Medication-related hospitalisations in patients with SLE by Arielle Mendel, Évelyne Vinet, Sasha Bernatsky, Christian A Pineau, Fares Kalache, Louis-Pierre Grenier, Emily G McDonald, Michèle Stanciu, Joo-Young Esther Lee, Gregory Clark

    Published 2025-01-01
    “…Renal involvement, polypharmacy, prednisone and immunosuppressant use were associated with hospitalisation related to an ADE, highlighting a vulnerable group.…”
    Get full text
    Article
  15. 195

    The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review by Jillian W. Wong, John Y. M. Koo

    Published 2012-01-01
    “…Patients with moderate-to-severe psoriasis are often treated with systemic immunosuppressant agents that decrease immune system function. …”
    Get full text
    Article
  16. 196

    Dermatomyositis following resection of thyroid and breast cancer: a case report and literature review by Miaomiao Yang, Jiannan Liu

    Published 2025-01-01
    “…This patient subsequently received systemic immunosuppressant therapy and thus dermatomyositis gradually resolved.ConclusionsA combination of thyroid cancer and breast cancer is thought to be very rare, especially in patients who develop dermatomyositis after thyroidectomy and mastectomy. …”
    Get full text
    Article
  17. 197

    Atypical Presentation of Kimura’s Disease in a Male Patient: A Case Report and Review of Literature by Zahra A. Natsha, Islam A. Hamarsheh, Rawan S. Utt, Bassam Abu Alrob, Adnan A. Wahdan

    Published 2022-01-01
    “…The patient was managed with steroids and an immunosuppressant (Azathioprine) with a moderate response for two years. …”
    Get full text
    Article
  18. 198

    Clinical Implications for the Timely Diagnosis of Mycobacterium marinum in the Age of Biologic Therapy: A Case Report and Review of the Literature by Chris J. Lata, Kelle Edgar, Stephen Vaughan

    Published 2017-01-01
    “…The natural history of this infection can be altered if the host is immunosuppressed, leading to disseminated presentations. …”
    Get full text
    Article
  19. 199

    Long-Term Clinical Behavior of Jejunoileal Involvement in Crohn’s Disease by Hugh J Freeman

    Published 2005-01-01
    “…Moreover, pharmacological therapies with corticosteroids and immunosuppressant drugs were rarely successful, with virtually all patients requiring at least one, and usually multiple, intestinal resections. …”
    Get full text
    Article
  20. 200

    Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient by Samuel Chan, Michael T. Burke, David W. Johnson, Ross S. Francis, David W. Mudge

    Published 2017-01-01
    “…The immunosuppressant tacrolimus has a narrow therapeutic window, necessitating therapeutic drug monitoring to maintain efficacy and minimise toxicity. …”
    Get full text
    Article